Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TC BioPharm Holdings (TCBPW)

  • Technical Exchange News
  • Aug. 21, 2024, 19:21 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

TC BioPharm Holdings (TCBP)

  • Technical Exchange News
  • Aug. 21, 2024, 19:21 UTC
  • 49
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Revelation Biosciences Inc. (REVBW)

  • Technical Exchange News
  • Aug. 21, 2024, 19:21 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revelation Biosciences Inc. (REVB)

  • Technical Exchange News
  • Aug. 21, 2024, 19:21 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cosmos Holdings Inc. (COSM)

  • Technical Exchange News
  • Aug. 21, 2024, 19:20 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Technical Exchange News
  • Aug. 21, 2024, 01:41 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Syra Health Corp (SYRA)

  • Technical Exchange News
  • Aug. 21, 2024, 01:41 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

TransCode Therapeutics Inc. (RNAZ)

  • Technical Exchange News
  • Aug. 21, 2024, 01:41 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

BioVie Inc. (BIVI)

  • Technical Exchange News
  • Aug. 21, 2024, 01:40 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Technical Exchange News
  • Aug. 20, 2024, 18:41 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 596
  • 597
  • 598
  • 599
  • 600
  • Next

Search

News categories

  • Technical Exchange News(11704)
  • Event(4028)
  • SEC News(231561)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(141780)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin